The GLP is committed to full transparency. Download and review our 2019 Annual Report

Large long-term farm study finds no statistically significant cancer link to glyphosate herbicide

| | November 9, 2017
This article or excerpt is included in the GLP’s daily curated selection of ideologically diverse news, opinion and analysis of biotechnology innovation.

A large long-term study on the use of the big-selling weedkiller glyphosate by agricultural workers in the United States has found no firm link between exposure to the pesticide and cancer, scientists said on Thursday [Nov. 9].

Published in the Journal of the National Cancer Institute (JNCI), the study found there was “no association between glyphosate”, the main ingredient in Monsanto’s popular herbicide RoundUp, “and any solid tumors or lymphoid malignancies overall, including non-Hogkin Lymphoma (NHL) and its subtypes.”

It said there was “some evidence of increased risk of acute myeloid leukemia (AML) among the highest exposed group”, but added “this association was not statistically significant” and would require more research to be confirmed.

Related article:  When the anti-GE science sucks, you can have it both ways

The findings are likely to impact legal proceedings taking place in the United States against Monsanto, in which more than 180 plaintiffs are claiming exposure to RoundUp gave them cancer – allegations that Monsanto denies.

“Glyphosate was not statistically significantly associated with cancer at any site,” the conclusion said.

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion, and analysis. Read full, original post: U.S. farm study finds no firm cancer link to Monsanto weedkiller

Share via
News on human & agricultural genetics and biotechnology delivered to your inbox.
Optional. Mail on special occasions.
Send this to a friend